Shield Therapeutics PLC (GB:STX)
LSE:STX
Want to see GB:STX full AI Analyst Report?
| Mar 26 | Dec 24 | Dec 23 | Dec 22 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 50.74M | £ 31.51M | £ 16.54M | £ 5.50M | £ 1.52M |
| Gross Profit | £ 22.38M | £ 13.22M | £ 5.09M | £ 2.46M | £ -1.67M |
| Operating Income | £ -10.30M | £ -22.87M | £ -39.60M | £ -26.39M | £ -20.41M |
| EBITDA | £ -9.16M | £ -20.74M | £ -38.28M | £ -46.07M | £ -17.69M |
| Net Income | £ -18.03M | £ -26.61M | £ -33.29M | £ -40.44M | £ -19.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 11.63M | £ 7.02M | £ 17.63M | £ 2.82M | £ 12.12M |
| Total Assets | £ 65.24M | £ 57.42M | £ 48.39M | £ 22.07M | £ 44.41M |
| Total Debt | £ 30.15M | £ 26.34M | £ 25.80M | £ 6.10M | £ 156.00K |
| Net Debt | £ 18.52M | £ 19.33M | £ 8.17M | £ 3.28M | £ -11.96M |
| Total Liabilities | £ 80.32M | £ 58.74M | £ 26.49M | £ 16.65M | £ 3.38M |
| Stockholders' Equity | £ -15.08M | £ -1.32M | £ 11.79M | £ 5.43M | £ 41.03M |
| Cash Flow | |||||
| Free Cash Flow | £ -8.83M | £ -8.80M | £ -50.65M | £ -20.14M | £ -18.80M |
| Operating Cash Flow | £ -8.81M | £ -8.77M | £ -46.93M | £ -18.25M | £ -16.74M |
| Investing Cash Flow | £ -306.29K | £ -2.37M | £ -3.07M | £ -1.70M | £ -2.05M |
| Financing Cash Flow | £ 13.75M | £ 5.26M | £ 62.77M | £ 7.71M | £ 27.58M |